insights_auto
Why is INO down ८.३३%?
Dive Deeperchevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
US$ १.४८
arrow_downward
-८.३३%(-०.१३) 1D
नोभेम्बर ५, ०९:५७:४२ GMT-५ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
US$ १.५७
High
US$ १.५९
Low
US$ १.४७
Mkt. cap
१५.३५ करोड
Avg. vol.
१.५७ करोड
Volume
३०.७७ लाख
52-wk high
US$ २.७२
52-wk low
US$ ०.५६
EPS
-US$ १.१७
Beta
१.७१
Shares outstanding
१०.३४ करोड
No. of employees
११२
Open
US$ १.५७
High
US$ १.५९
Low
US$ १.४७
Mkt. cap
१५.३५ करोड
Avg. vol.
१.५७ करोड
Volume
३०.७७ लाख
52-wk high
US$ २.७२
52-wk low
US$ ०.५६
EPS
-US$ १.१७
Beta
१.७१
Shares outstanding
१०.३४ करोड
No. of employees
११२
News stories
From web sources and news partners
Kalkine
·
१ दिन पहिले
What Comes Next for Inovio (NASDAQ:INO) After a 224% Jump on Accelerated Approval?
News Corp
·
१ दिन पहिले
Inovio Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors
Yahoo Finance
·
२ दिन पहिले
INOVIO to Report Third Quarter 2026 Financial Results on November 10, 2026
Yahoo Finance
·
२ दिन पहिले
Update: Inovio Shares Surge After HC Wainwright Upgrade Following FDA Approval for Voceryq
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc